Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in perinatal delta9-tetrahydrocannabinol occurs in schizophrenia: analyses in patients and in animal model of the disease

Vztah mezi regulací trankripce D2 a CB1 receptorů v perimatálním delta9-tetrahydrocannabinolovém modelu a u pacientů se schizofrenií

DI BARTOLOMEO, Martina (380 Italy), Tibor ŠTARK (703 Slovakia, belonging to the institution), Maurel ORIANA MARIA (380 Italy), Fabio Arturo IANNOTTI (380 Italy), Martin KUCHAR (203 Czech Republic), Jana RUDÁ (203 Czech Republic, belonging to the institution), Fabiana PISCITELLI (380 Italy), Samuele LAUDANI (380 Italy), Vladimír PEKAŘÍK (203 Czech Republic, belonging to the institution), Salvatore SALOMONE (124 Canada), Beatrice AROSIO (380 Italy), Raphael MECHOULAM, Mauro MACCARRONE (380 Italy), Filippo DRAGO (380 Italy), Carsten WOTJAK (276 Germany), Vincenzo DI MARZO (380 Italy), Matteo VISMARA (380 Italy), Bernardo DELL'OSSO (380 Italy), Claudio D'ADDARIO (380 Italy) and Vincenzo MICALE (380 Italy, guarantor)

PHARMACOLOGICAL RESEARCH, London, ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD, 2021, 1043-6618

English

Článek v odborném periodiku

30104 Pharmacology and pharmacy

United Kingdom of Great Britain and Northern Ireland

není předmětem státního či obchodního tajemství

URL

RIV/00216224:14110/21:00120866

Faculty of Medicine

000615153300017

Schizophrenia; THC; Cannabinoid CB1 receptor; Dopamine D2 Receptor; Cannabidiol; DNA methylation; Epigenetics

14110515, 14110516, rivok

International impact, Reviewed